Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy

Acta Neurol Scand. 1991 Jun;83(6):399-402. doi: 10.1111/j.1600-0404.1991.tb03971.x.

Abstract

Acute symmetric demyelinating polyneuropathy of the Guillain-Barré type is known in systemic lupus erythematosus (SLE). Chronic idiopathic demyelinating polyneuropathy (CIDP) has been reported rarely with SLE. A case is reported of CIDP accompanying SLE with autoantibodies against GM1- and GM3-gangliosides. There was no historical evidence to suggest SLE, and CIDP was the first manifestation of SLE. The 38-year-old patient had elevated CSF-protein, slow nerve conduction velocities, sural nerve biopsy revealed mixed axon loss with demyelination and CIDP white matter lesions were observed in magnetic resonance imaging, the GM1- and GM3-autoantibodies may play a role in the pathogenesis of CIDP in SLE.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Autoantibodies / analysis*
  • Chronic Disease
  • Demyelinating Diseases / diagnosis
  • Demyelinating Diseases / immunology
  • G(M1) Ganglioside / immunology*
  • G(M2) Ganglioside / analysis*
  • Humans
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Neurologic Examination
  • Polyradiculoneuropathy / diagnosis
  • Polyradiculoneuropathy / immunology*

Substances

  • Autoantibodies
  • G(M2) Ganglioside
  • G(M1) Ganglioside